Update on Alport Syndrome: The Report of the 2024 International Workshop on Alport Syndrome - PubMed
5 hours ago
- #Genetic Disorders
- #Nephrology
- #Alport Syndrome
- The 2024 International Workshop on Alport Syndrome gathered patients, clinicians, scientists, and pharmaceutical representatives to discuss advancements.
- Focus areas included diagnosis, genetic variant curation, and treatment strategies for diverse Alport syndrome phenotypes.
- Advances in genetic testing for non-European populations and challenges in variant interpretation were key topics.
- Novel treatments like gene therapy and ongoing trials (e.g., SGLT2 inhibitors, endothelin receptor antagonists) show promise in preserving kidney function.
- Collaboration between high- and low-to-middle-income countries was emphasized to address diagnostic disparities.
- Patient advocacy and nephrology education were highlighted as crucial for improving outcomes.
- Alport syndrome is progressing toward becoming a highly treatable condition with potential to prevent kidney failure.